Dilapan-S Versus Double Balloon Catheter (CRB) for Preinduction of Labor at Term
1 other identifier
interventional
126
0 countries
N/A
Brief Summary
Induction of labor (IOL) is a frequently performed procedure in obstetrics, aimed to achieve vaginal delivery when continuing the pregnancy is no longer advisable. A key determinant of IOL success is cervical ripening, particularly when the cervix is initially unfavorable. A range of preinduction methods is available, encompassing both mechanical and pharmacological approaches. Among mechanical techniques, the double balloon catheter (CRB) facilitates cervical dilation by applying direct pressure, which stimulates local prostaglandin release. In contrast, Dilapan-S, a synthetic osmotic dilator, works by gradually expanding through the absorption of cervical fluids, thereby applying gentle mechanical pressure. While both methods are widely used and generally considered safe, there is limited evidence directly comparing their effectiveness and patient-centered outcomes. Mechanical methods are associated with a lower risk of uterine hyperstimulation compared to pharmacological alternatives. The choice between CRB and Dilapan-S may significantly influence labor duration, cesarean delivery rates, maternal comfort, and hospital resource utilization. This study aims to fill the existing knowledge gap by directly comparing Dilapan-S and CRB for term preinduction, with a focus on clinical efficacy and maternal satisfaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 12, 2025
CompletedFirst Posted
Study publicly available on registry
June 8, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
June 8, 2025
May 1, 2025
1 year
May 12, 2025
May 29, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Time from initiation of cervical ripening to time of delivery measure in hours and minutes
from the time of beginning of cervical ripening to the time of delivery measure in hours and minutes
Secondary Outcomes (10)
Change in Bishop score after device removal
From the time of beggining of cervical ripening to the time of removal of the device (CRB or dilapan S) 12 hours
Mode of delivery
at the time of delivery
Need for additional ripening agent
From removal of CRB or dilapanS to 96 hours after enrollment
Maternal discomfort assessed by VAS
from CRB insertion or DilapanS removal (12 hours)
Apgar Score
at the time of delivery
- +5 more secondary outcomes
Study Arms (2)
Dilapan-S
EXPERIMENTALDilapan-S Participants assigned to the Dilapan-S group will have 3 to 5 rods inserted under aseptic conditions. Placement will follow manufacturer instructions, and rods will remain in place for up to 12 hours unless spontaneous labor or device expulsion occurs earlier. Upon removal, cervical status will be assessed, and induction will continue with prostaglandins or oxytocin based on standard care
Double Balloon Catheter (CRB)
ACTIVE COMPARATORParticipants randomized to CRB will undergo insertion of a double balloon catheter with inflation of each balloon (approximately 80 mL saline each) according to established protocols. The catheter will remain for up to 12 hours or until spontaneous labor or expulsion. Post-removal management will mirror that of the Dilapan-S group.
Interventions
Participants assigned to the Dilapan-S group will have 3 to 5 rods inserted under aseptic conditions. Placement will follow manufacturer instructions, and rods will remain in place for up to 12 hours unless spontaneous labor or device expulsion occurs earlier. Upon removal, cervical status will be assessed, and induction will continue with prostaglandins or oxytocin based on standard care.
Double Balloon Catheter (CRB) Participants randomized to CRB will undergo insertion of a double balloon catheter with inflation of each balloon (approximately 80 mL saline each) according to established protocols. The catheter will remain for up to 12 hours or until spontaneous labor or expulsion. Post-removal management will mirror that of the Dilapan-S group.
Eligibility Criteria
You may qualify if:
- Singleton pregnancy
- Cephalic fetal presentation
- Gestational age ≥ 37+0 weeks
- Indication for labor induction (e.g., postdates, maternal hypertension)
- Bishop score ≤ 6
- Maternal age ≥18 years
- Ability to provide informed consent
You may not qualify if:
- Premature rupture of membranes (PROM)
- Placenta previa, vasa previa, or abnormal placentation
- Active genital tract infection
- Prior classical cesarean section or extensive uterine surgery
- Known fetal anomaly contraindicating vaginal delivery
- Allergy or sensitivity to device materials
- Any contraindication to labor induction or vaginal birth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Giuseppe Rizzo
Study Record Dates
First Submitted
May 12, 2025
First Posted
June 8, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
June 8, 2025
Record last verified: 2025-05